蛋白棕化:在心血管疾病中是一种潜在的治疗点
Sijia Zhao1, Yanyan Yang2, Hong Li3
1Department of Cardiac Ultrasound, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
Acta pharmaceutica Sinica. B
|October 24, 2025
概括
棕化是一种关键的蛋白质修饰,调节细胞功能,在心血管疾病中至关重要. 向棕化提供了对心脏病有前途的新治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 棕化是一种关键的翻译后修饰,涉及棕酸盐与蛋白质中的氨酸残留物结合.
- 这种脂质修饰调节蛋白质功能,膜局部化,蛋白质降解和细胞内运输.
- 在心血管疾病的发展和进展中,越来越多地认识到手掌细胞调节失调.
研究的目的:
- 审查棕细胞化在心血管疾病发病过程中的多方面的作用.
- 在心血管环境中探索参与蛋白质棕化过程中的酶和基质.
- 突出针对心血管病理的棕化治疗的治疗潜力.
主要方法:
- 关于手掌化和心血管疾病的当前研究的文献综述.
- 对调节功能,催化酶和蛋白质基质的分析.
- 检查最近的发现和治疗策略与棕结合有关.
主要成果:
- 棕化对蛋白质局部化,稳定性和与心血管健康相关的相互作用产生了关键的影响.
- 已经确定了在心血管系统中调解棕化作用的特定酶和基质.
- 有证据表明,调节棕细胞代谢可以影响心血管疾病的进展.
结论:
- 棕化是心血管病理生理学的重要调节剂,提供潜在的治疗点.
- 专注于棕托异化通路的有针对性的干预措施代表了新型心血管治疗的前沿.
- 需要进一步的研究,以充分阐明治疗潜力,并克服临床应用中的挑战.
相关概念视频
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Coronary Artery Disease II: Pathophysiology
366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366
Lipids as Anchors
7.2K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
7.2K
Peripheral Artery Disease III: Interprofessional Care
237
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
237
Coronary Artery Disease IV: Preventive Measures
584
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
584


